Hearing aids tested to ease chemotherapy side effect
NCT ID NCT05936034
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether hearing aids can improve quality of life in cancer patients who develop hearing loss from platinum-based chemotherapy. Fifty-two adults currently on such chemotherapy and with confirmed hearing loss will be randomly assigned to receive a hearing aid or standard care. Their quality of life, hearing, and tinnitus will be measured over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hearing aid
- What this could lead to
- If it works, this could show that hearing aids meaningfully improve quality of life for cancer patients with chemotherapy-induced hearing loss.
- What could go wrong
- This is a small, early-stage study with only 52 participants. The benefit may be modest or not apply to all patients, and hearing aids may not be well-tolerated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut de Cancerologie de Lorraine
RECRUITINGVandœuvre-lès-Nancy, 54500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Smartwatch could spot nerve damage before it starts
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?